BIONTECH SE SPON. ADRS 1
Commented by Mario Hose on April 24th, 2020 | 07:36 CEST
BioNTech, Gilead, Memphasys - in the spotlight of investors overnight
There are topics and products that are the focus of general interest overnight. Often these are needs or problems that require a time-critical solution. The current situation surrounding the spread of the Corona Virus COVID-19 has brought numerous companies into the focus of investors in recent weeks. The backgrounds are of a very different nature. On the one hand, there are manufacturers of masks, disinfectants or respiratory equipment, as well as medical companies that may have an active ingredient for the prevention or therapy of the Corona Virus on offer. But there are also topics that are beyond the general interest and represent a huge market.
Read
Commented by Mario Hose on April 15th, 2020 | 08:10 CEST
BioNTech, Evotec, EXMceuticals - Stocks with potential
Health is the most important thing in life. The current protective measures around the globe in connection with the spread of the Corona Virus Covid-19 show how great the fear and helplessness is. Above all, this pandemic has highlighted the extent of the global dependence on China as a supplier of medicines or medical ingredients and protective clothing. Supply chains will get shorter. Individuals and societies will be more focused on health and wellness. In view of the time after the current Corona Crisis it is expected that politics and the economy will reorganize and reposition themselves.
Read
Commented by Mario Hose on March 19th, 2020 | 11:25 CET
BioNTech, Gilead, Memphasys - modern science and COVID and IVF
People around the world are worried about the extent of the consequences associated with the spread of the corona virus COVID-19, and politicians and the economy are called upon to deal with the situation appropriately so that the loss of life and financial damage to the citizens can be kept to a minimum. Medical experts are now working intensively to ensure that active substances for prevention and therapy are tested and made ready for the market.
Read